Viruses 2009, 1(2), 144-165; doi:10.3390/v1020144
Review

Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives

Division of Viral Products, Center for Biologics, Food and Drug Administration, Bldg29A/Rm1D10, 8800 Rockville Pike, Bethesda, MD 20892, USA
Received: 3 June 2009; in revised form: 25 July 2009 / Accepted: 11 August 2009 / Published: 12 August 2009
(This article belongs to the Special Issue Hepatitis Viruses)
PDF Full-text Download PDF Full-Text [291 KB, uploaded 21 August 2009 00:43 CEST]
Abstract: Studies in patients and chimpanzees that spontaneously clear Hepatitis C Virus (HCV) have demonstrated that natural immunity to the virus is induced during primary infections and that this immunity can be cross protective. These discoveries led to optimism regarding prophylactic HCV vaccines and a number of studies in the chimpanzee model have been performed, all of which resulted in modified infections after challenge but did not always prevent persistence of the virus. Therapeutic vaccine strategies have also been pursued in an effort to reduce the costs and side effects associated with anti-viral drug treatment. This review summarizes the studies performed thus far in both patients and chimpanzees for prophylactic and therapeutic vaccination, assesses the progress made and future perspectives.
Keywords: vaccine; immune responses; immunotherapy; T cells; neutralizing antibody

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Major, M.E. Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives. Viruses 2009, 1, 144-165.

AMA Style

Major ME. Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives. Viruses. 2009; 1(2):144-165.

Chicago/Turabian Style

Major, Marian E. 2009. "Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives." Viruses 1, no. 2: 144-165.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert